Parkinsonian DisordersInorganic ChemicalsSupranuclear Palsy, ProgressiveMultiple System AtrophyParkinson DiseaseLevodopaParkinson Disease, SecondaryAntiparkinson Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineBrain NeoplasmsGlobus PallidusHypokinesiaMuscle RigidityBrain ChemistrySubthalamic NucleusDyskinesia, Drug-InducedBipolar DisorderBrain InjuriesOxidopamineSubstantia NigraBrainTumor Markers, BiologicalTumor Necrosis Factor-alphaTremorCorpus StriatumTumor BurdenBrain MappingDeep Brain StimulationDyskinesiasExtrapyramidal TractsMental DisordersCell Line, TumorDopamineCarbidopaMagnetic Resonance ImagingBasal GangliaMood DisordersAnxiety DisordersDopamine AgentsDisease Models, AnimalMovement DisordersNeuronsOlivopontocerebellar AtrophiesWilms TumorBenserazideMazindolTime FactorsNeoplasms, ExperimentalGenes, Tumor SuppressorDiagnostic and Statistical Manual of Mental Disorders